Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Manufactures and sells pharmaceuticals

Shenzhen Ausa Pharmed Co. Ltd. is a private company headquartered in China. The firm provides drug clinical trail services.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Jiangxi Ganyao New Pharmaceutical Co., Ltd., part of Jiangxi Youzhang Biotechnology Co., Ltd., is a company headquartered in Yichun, China. The firm provides biological technology development services for medicine, energy and environmental protection. It was founded in 2005.

Zhejiang Tailisen Pharmaceutical Co., Ltd., established on 1995-12-29, Business range includes tablet,hard capsule,Granules,Mixture manufacturing,processing(Operating with a valid drug production license).

Bioalpha International Sdn. Bhd. operates as an investment holding company with interests in manufacturing and selling of health supplement and herbal nutraceutical products. The company was founded by Tian Kok Hon in November 2005 and is headquartered in Petaling Jaya, Malaysia.

Beijing Huaanfo Pharmaceutical Research Center Co., Ltd., established on 2003-01-29, Business scope includes pharmacogenomics,predictive medicine,Cancer Genomics,Technology development of new drugs,technology transfer,technical consulting.(Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments.)

ONO Pharmaceutical is focused on the production, purchase, and sale of pharmaceuticals and diagnostic reagents on prescription pharmaceuticals. The company focuses on drug discovery leads that are high in certainty and globally competitive. The company was started in 1717 in Dosho-machi, Osaka. Throughout its 300-year history, ONO has dedicated itself to developing innovative and breakthrough pharmaceutical products.

Ajinomoto Co. is a global manufacturer of high-quality seasonings, processed foods, beverages, amino acids, pharmaceuticals and specialty chemicals. For many decades Ajinomoto Co. has contributed to food culture and human health through wide-ranging application of amino acid technologies. Today, the company is becoming increasingly involved with solutions for improved food resources, human health and global sustainability. Founded in 1909 and now operating in 26 countries, Ajinomoto Co. had net sales of JPY 1,197.3 billion (USD 15.1 billion) in fiscal 2011. The Ajinomoto Group Standards of Business Conduct (hereinafter the "Standards of Conduct") describe the conduct that every member of the Ajinomoto Group must understand and practice every day in order to implement the Ajinomoto Group Philosophy in accordance with the Ajinomoto Group Way. The Standards of Conduct also represent the commitments made to all stakeholders by Ajinomoto Group companies. Ajinomoto aim to be "a group of companies that contributes to human health globally" by continually creating unique value to benefit customers. To become a global group of food companies centered on the world's No. 1 seasoning business. To become a global group of aminoscience companies that contributes to humankind with the world's No. 1 amino acid technology. To become a group of health-promoting companies with a scientific approach to good taste and health.

Jiangsu Defeng Pharmaceutical Co., Ltd., established on 2007-07-20, The scope of business includes the production of chemical products(5-Phenyl tetrazole,5-Aminotetrazolium,5-methyl tetrazole,Phenylboronic acid,Production of methyl o-iodobenzoate,Sales).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Hunan Hill Natural Pharmaceutical Co., Ltd., established on 1996-11-21, Business scope includes pharmaceuticals,Healthy food,Research and development of food and food additives,production and sales;Sales of prepackaged food.Natural material extraction and process equipment research.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Mochida Pharmaceutical is a drug manufacturing company. Their pharmaceutical business aims to develop and market a broad spectrum of innovative new drugs. They also offer creates skin care products for the general public, and these are supplied through pharmacies, and drugstores.

Qing Ru Lan （ Da Lian ） Ke Ji You Xian Gong Si, established on 2019-09-05, Business scope includes environmental protection technology development,Production and sales of environmentally friendly products;air purification device,Testing Instrument Technology,food,Technology development of health products,technical consulting,Technical Services,Technology Transfer and Sales;laboratory reagent,Production and sales of consumables and biological reagents;Special equipment for environmental protection,Pre-packaged food,Sales of health products;IProduction and sales of similar medical devices;Medical equipment technology development,On-site installation,Field Repair and Sales;goods,Technology Import and Export;Domestic general trade.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Shenzhen Osa Pharmaceutical Co., Ltd., established on 1998-12-15, Business scope includes general business items:Invest in business(Specific projects will be reported separately);Domestic Trade(Does not contain franchise,Exclusive control,Monopoly);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating);biomedical technology,Biotechnology research and development and consulting(No restricted items).Cosmetics Retail;General merchandise sales;Sales of agricultural and sideline products;Disinfectant sales(Free of Hazardous Chemicals);Sales of daily chemical products;Cosmetics Wholesale;Retailing of Class II Medical Devices.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license),The licensing program is:In vitro diagnostic reagents(Except special management diagnostic reagents)promotion of;Chemical API,Wholesale of chemical preparations;one type,Class II,Sales of Class III Medical Devices.Disinfection equipment sales;Healthy food(prepackaged)Sales;food sales;Drug retail;Class III medical device business;Drug Wholesale.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Jiren Pharmaceutical Linzhou Co., Ltd., established on 2007-10-17, Business scope includes mixture(Contains traditional Chinese medicine pretreatment and extraction)And the import and export business of the company's products;Polygonatum Lycium Berry Plant Beverage,Polygonatum and wolfberry wine.

Xinjiang Uygur Pharmaceutical Co., Ltd., a subsidiary of Humanwell Healthcare (Group) Co., Ltd., is a Chinese company located in Urumqi. The firm manufactures pharmaceutical products.

Research Corporation Technologies, Inc. provides investment related services. It operates as technology development company that typically invests in new technology platforms in life sciences, healthcare technology, biomedical, preclinical and clinical-stage therapeutics, devices, drugs, and diagnostics, medical devices, and biotech tools for gene expression and protein production with medical devices. The company was founded in 1987 and is headquartered in Tucson, AZ.

Hebei Baixiaodan is a key enterprise in Anguo, the pharmaceutical capital of China's traditional Chinese medicine distribution center, with a total area of 132000 square meters and an investment of 670 million yuan. It is one of the R&D and production bases for the deep processing of traditional Chinese medicine and the homologous products of medicine and food in North China; Take the lead in building a transparent factory model; The initiator and business unit of Hebei Great Health Industry Innovation Alliance; Domestic enterprises that introduce value-added services of women's health management portfolio. As of 2019, the brand of Bavarian has a history of 25 years, among which, the Meiling Pill products under Bavarian Group created a myth of annual sales of 7 billion single products. At present, the company has 96 approvals for dietary supplements. Its main business is the design of women's health management solutions, as well as the research, development, production and sales of women's health products. Hebei Baixiaodan's mission is to adhere to the brand management concept of "health origin" and provide women customers with high-quality health management solutions, products and services. The health management solution is mainly based on self-developed products, designed and developed the application series product portfolio of the group, and introduced consumer health management mechanism and services. Hebei Baixiaodan not only provides customers with combined and usable products, but also creates health files, personal health assessment, customized personalized health programs, online health consultation, health guidance and other services for consumers based on Internet plus. The company is committed to providing women customers with the most advanced "health management" services. The path to achieve the strategic goal of Hebei Baixiaodan is to strengthen the core competitiveness of the company and make the company bigger and stronger. In the next few years, the company will focus on the construction of two core competitiveness: brand building and marketing network construction.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.